Pfizer will not use the government’s vaccine distribution partner, McKesson, to distribute its Covid-19 vaccine in the US if it is authorized, the company said in a statement on Thursday.
Instead, it will use its own distribution system to deliver the vaccine directly to health care providers.
Once the vaccine is approved by the US Food and Drug Administration, the company plans on shipping out 7.6 million doses per day from its facilities in Kalamazoo, Michigan, and Puurs, Belgium.
Distribution will be challenging because the Pfizer vaccine must be kept at a temperature of negative 103 Fahrenheit while being stored. Pfizer has designed shipping containers roughly the size of a suitcase that can maintain that temperature for up to 10 days.
Pfizer says its distribution plan was approved by the US government and is built on what the company calls a “flexible just in time system which will ship the frozen vials directly from our plants to the point of vaccination.”
In a statement provided to CNN, the company reported that for the US market, “our distribution will be direct from Kalamazoo to point-of-use (POU), or our distribution center at Pleasant Prairie, WI to the points of vaccination or equivalent location. We continue to work very closely with the US Government on ensuring an effective distribution model.”